|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.75 USD | -3.22% |
|
-1.85% | +11.18% |
| 01-15 | Trump Launches Health Care Plan to Reduce Drug Costs | MT |
| 01-12 | Health Care Down on Health-Insurance Concerns -- Health Care Roundup | DJ |
| Capitalization | 22.49B 19.32B 17.94B 16.76B 31.19B 2,043B 33.51B 207B 81.48B 973B 84.32B 82.59B 3,557B | P/E ratio 2025 * |
-4.53x | P/E ratio 2026 * | 23.3x |
|---|---|---|---|---|---|
| Enterprise value | 25.8B 22.16B 20.58B 19.23B 35.78B 2,344B 38.45B 237B 93.48B 1,116B 96.74B 94.75B 4,081B | EV / Sales 2025 * |
0.13x | EV / Sales 2026 * | 0.13x |
| Free-Float |
79.74% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Centene Corporation
| 1 day | -3.22% | ||
| 1 week | -1.85% | ||
| Current month | +11.18% | ||
| 1 month | +16.65% | ||
| 3 months | +29.71% | ||
| 6 months | +63.69% | ||
| Current year | +11.18% |
| 1 week | 45.59 |  | 47.68 |
| 1 month | 38.58 | | 47.68 |
| Current year | 40.53 | | 47.68 |
| 1 year | 25.08 | | 66.81 |
| 3 years | 25.08 | | 81.42 |
| 5 years | 25.08 | | 98.53 |
| 10 years | 23.68 | | 98.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 45 | 2022-03-21 |
Drew Asher
DFI | Director of Finance/CFO | 57 | 2021-05-06 |
Susan Smith
COO | Chief Operating Officer | 50 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 2023-03-30 | |
Jessica Blume
BRD | Director/Board Member | 71 | 2018-02-04 |
H. Dallas
CHM | Chairman | 67 | 2022-02-22 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.16% | 1.41% | 26 M€ | |
| 0.00% | 1.31% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.22% | -1.85% | -26.51% | -39.07% | 22.49B | |
| -2.34% | -3.77% | -35.06% | -30.49% | 300B | |
| -1.85% | +0.55% | -2.70% | -20.53% | 83.31B | |
| -2.06% | -2.42% | -4.15% | -11.72% | 72.71B | |
| -3.76% | -1.29% | -3.31% | -43.62% | 32.87B | |
| -1.21% | +5.45% | -33.13% | -35.16% | 9.84B | |
| 0.00% | +8.28% | +54.32% | +86.41% | 4.5B | |
| +0.86% | -9.15% | +16.76% | -26.87% | 2.11B | |
| Average | -1.70% | -0.53% | -4.22% | -15.13% | 65.96B | |
| Weighted average by Cap. | -2.30% | -2.41% | -22.35% | -26.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 193B 166B 154B 144B 268B 17,524B 287B 1,775B 699B 8,343B 723B 708B 30,507B | 193B 166B 154B 144B 268B 17,537B 288B 1,776B 699B 8,349B 724B 709B 30,530B |
| Net income | -4.21B -3.61B -3.36B -3.13B -5.83B -382B -6.27B -38.71B -15.24B -182B -15.77B -15.45B -665B | 883M 758M 704M 658M 1.22B 80.21B 1.32B 8.12B 3.2B 38.19B 3.31B 3.24B 140B |
| Net Debt | 3.31B 2.85B 2.64B 2.47B 4.59B 301B 4.94B 30.48B 12B 143B 12.42B 12.17B 524B | 1.87B 1.6B 1.49B 1.39B 2.59B 170B 2.78B 17.19B 6.77B 80.81B 7.01B 6.86B 296B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 45.75 $ | -3.22% | 7,084,420 |
| 26-01-15 | 47.27 $ | +2.38% | 4,919,516 |
| 26-01-14 | 46.17 $ | +0.90% | 4,546,995 |
| 26-01-13 | 45.76 $ | -1.36% | 4,436,470 |
Delayed Quote Nyse, January 16, 2026 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CNC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition